← Open Payments lookup

IRENE NEVAREZ: Open Payments

NPI 1003166646 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,490 in 54 payments from 11 companies in 2025. Trend: 2023 $944 · 2024 $452 · 2025 $1,490

Food & beverage: $1,378Education: $111
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.7$247
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)8$239
Neurocrine BioSciences, Inc.9$236
Teva Pharmaceuticals USA, Inc.6$232
Alkermes, Inc.10$211
Otsuka America Pharmaceutical, Inc.5$121
ABBVIE INC.3$74
Supernus Pharmaceuticals, Inc.2$47
Janssen Pharmaceuticals, Inc2$43
Lundbeck LLC1$21

Products named: FANAPT, CAPLYTA, INGREZZA, ARISTADA, UZEDY, REXULTI, VRAYLAR, Qelbree.

Industry payments across CA — which companies pay providers there.